Clinical Value Of Serum Levels Of 11-Oxygenated Metabolites Of Testosterone In Women With Polycystic Ovary Syndrome

Context/objective: Recent data suggested that 11-oxygenated androgens may be the preponderant circulating androgens in women with PCOS. However, the pathophysiological significance of these hormones remains unclear. The aim of this study was to evaluate the relationships between serum 11-OH testosterone (11-OHT) and 11-Keto testosterone (11-KetoT) and clinical and biochemical hyperandrogenism, as well as the metabolic parameters, in women with PCOS. Subjects: One hundred and twenty-three women with PCOS, diagnosed according to the Rotterdam criteria, and 38 healthy controls. Design: The main classic and 11-oxygenated androgens were measured by LC-MS/MS and direct equilibrium dialysis. Insulin sensitivity was assessed by hyperinsulinemic euglycemic clamp. Results: Serum 11-oxygenated androgens were higher in women with PCOS than in controls. Elevated levels of 11-OHT and 11-KetoT were found in 28.5% and 30.1% of PCOS women, respectively, whereas free testosterone (FT) was increased in 61.0% of them. Serum 11-oxygenated androgens showed a limited performance in recognizing women with classically-defined hyperandrogenism. Unlike FT, 11-oxygenated androgens did not show significant relationships with anthropometric and metabolic parameters, except for a direct association with insulin sensitivity. In multivariable analysis, 11-OHT and 11-KetoT, directly, and FT, inversely, remained significant independent predictors of insulin sensitivity. Conclusions: Serum levels of 11-oxygenated androgens are higher in women with PCOS than in controls. However, these hormones show a poor performance in recognizing women with hyperandrogenism, as currently defined. The relationships of these androgens with insulin sensitivity strongly differ from that of FT, suggesting a different role of classic and 11-oxygenated androgens in the pathophysiology of PCOS.